[HTML][HTML] Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine

L Ye, S Fan, P Zhao, C Wu, M Liu, S Hu, P Wang… - … Pharmaceutica Sinica B, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Effective treatments against …

Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties …

LM Shinyuy, GE Loe, O Jansen, L Mamede, A Ledoux… - Metabolites, 2023 - mdpi.com
There are over 500 species of the genus Artemisia in the Asteraceae family distributed over
the globe, with varying potentials to treat different ailments. Following the isolation of …

[HTML][HTML] An O-methylflavone from Artemisia afra kills non-replicating hypoxic Mycobacterium tuberculosis

JJ Kellogg, MN Alonso, RT Jordan, J Xiao… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance African wormwood (Artemisia afra Jacq. ex Willd.)
has been used traditionally in southern Africa to treat illnesses causing fever and was …

Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages

A Maciuk, D Mazier, R Duval - Natural product reports, 2023 - pubs.rsc.org
Covering: up to 2023 Infusions of the plants Artemisia annua and A. afra are gaining broad
popularity to prevent or treat malaria. There is an urgent need to address this controversial …

Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income …

DJ Smith, H Bi, J Hamman, X Ma, C Mitchell… - Frontiers in …, 2023 - frontiersin.org
The COVID-19 pandemic sparked the development of novel anti-viral drugs that have shown
to be effective in reducing both fatality and hospitalization rates in patients with elevated risk …

Artemisia afra and Artemisia annua Extracts Have Bactericidal Activity against Mycobacterium tuberculosis in Physiologically Relevant Carbon Sources and …

BH Kiani, MN Alonso, PJ Weathers, SS Shell - Pathogens, 2023 - mdpi.com
Mycobacterium tuberculosis (Mtb) is a deadly pathogen and causative agent of human
tuberculosis, causing~ 1.5 million deaths every year. The increasing drug resistance of this …

[HTML][HTML] Global research trends on herbal tea: a bibliometric and visualized analysis

W Kong, L Jiang, Q Cui, J Xu, Q Yuan… - Beverage Plant …, 2024 - maxapress.com
Herbal tea, being a beverage with medicinal and edible properties, has served a significant
role in promoting health and preventing diseases, leading to ongoing research …

Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to Artemisia sp., Artemisinin, and Its Derivatives

P Weathers, M Towler, BH Kiani, D Dolivo, T Dominko - Molecules, 2024 - mdpi.com
Fibrosis is a ubiquitous pathology, and prior studies have indicated that various artemisinin
(ART) derivatives (including artesunate (AS), artemether (AM), and dihydroartemisinin …

Artemisia annua, a cost-effective sustainable therapeutic for the masses and the political challenges for its implementation

P Weathers, M Desrosiers, L Cornet-Vernet - 2023 - degruyter.com
Malaria, caused by Plasmodium species and transmitted by mosquitos, is one of the number
of neglected tropical diseases with 241 million cases in 2020, a rise> 6% compared to 2019 …

Artemisia afra and Artemisia annua Extracts Have Bactericidal Activity against Mycobacterium tuberculosis in Physiologically Relevant Carbon Sources and Hypoxia

B Hafeez Kiani, MN Alonso, PJ Weathers, SS Shell - 2023 - ri.conicet.gov.ar
Mycobacterium tuberculosis (Mtb) is a deadly pathogen and causative agent of human
tuberculosis, causing~ 1.5 million deaths every year. The increasing drug resistance of this …